AC Immune SA (ACIU)
3.23
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 21, 14:30
AC Immune Price: 3.23 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 3.27 | 3.41 | 3.22 | 3.24 | 58632.00 |
Nov 19, 2024 | 3.12 | 3.33 | 3.118 | 3.27 | 100751.0 |
Nov 18, 2024 | 3.20 | 3.310 | 3.11 | 3.135 | 84347.00 |
Nov 15, 2024 | 3.53 | 3.55 | 3.13 | 3.19 | 234162.0 |
Nov 14, 2024 | 3.30 | 3.88 | 3.29 | 3.55 | 758923.0 |
Nov 13, 2024 | 3.04 | 3.22 | 3.00 | 3.13 | 88258.00 |
Nov 12, 2024 | 3.11 | 3.170 | 3.00 | 3.06 | 115657.0 |
Nov 11, 2024 | 3.20 | 3.29 | 3.12 | 3.17 | 244247.0 |
Nov 08, 2024 | 3.23 | 3.23 | 3.12 | 3.20 | 74226.00 |
Nov 07, 2024 | 3.15 | 3.275 | 3.11 | 3.27 | 79988.00 |
Nov 06, 2024 | 3.28 | 3.28 | 3.02 | 3.09 | 104654.0 |
Nov 05, 2024 | 3.08 | 3.28 | 3.02 | 3.24 | 143664.0 |
Nov 04, 2024 | 3.00 | 3.09 | 2.89 | 2.94 | 84079.00 |
Nov 01, 2024 | 2.86 | 3.00 | 2.85 | 3.00 | 73043.00 |
Oct 31, 2024 | 2.89 | 2.97 | 2.80 | 2.84 | 96967.00 |
Oct 30, 2024 | 2.97 | 3.015 | 2.97 | 2.97 | 66704.00 |
Oct 29, 2024 | 3.04 | 3.04 | 2.95 | 3.01 | 40257.00 |
Oct 28, 2024 | 3.05 | 3.12 | 2.95 | 3.00 | 73391.00 |
Oct 25, 2024 | 3.00 | 3.09 | 2.99 | 3.05 | 46247.00 |
Oct 24, 2024 | 3.08 | 3.10 | 2.99 | 3.00 | 86828.00 |
Oct 23, 2024 | 3.14 | 3.232 | 2.92 | 3.04 | 136932.0 |
Oct 22, 2024 | 3.04 | 3.15 | 3.02 | 3.11 | 129468.0 |
Oct 21, 2024 | 3.14 | 3.240 | 3.03 | 3.07 | 123784.0 |
Oct 18, 2024 | 3.26 | 3.365 | 3.06 | 3.13 | 122281.0 |
Oct 17, 2024 | 3.21 | 3.22 | 3.18 | 3.21 | 54198.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.72
Minimum
Dec 22 2022
9.89
Maximum
Jan 15 2020
4.719
Average
3.99
Median
Apr 08 2022
Price Benchmarks
CRISPR Therapeutics AG | 46.30 |
Addex Therapeutics Ltd | 7.89 |
NLS Pharmaceutics Ltd | 3.36 |
Molecular Partners AG | 5.34 |
MoonLake Immunotherapeutics | 51.63 |
Price Related Metrics
Price to Book Value | 2.066 |
Price to Free Cash Flow | 6.080 |
Earnings Yield | -14.21% |
Market Cap | 319.59M |